Planet Briefing

First published · Last updated

Aspirin exerts anti-tumor effect through inhibiting Blimp1 and activating ATF4/CHOP pathway in multiple myeloma

A 2020 journal article reports that aspirin exerts an anti-tumor effect in multiple myeloma by inhibiting Blimp1 and activating the ATF4/CHOP pathway. The supplied source fields include only the title, publisher, and publication date with no additional experimental details.

Categories: science-and-space, public-health, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
4/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
2/10
Positivity
6/10
Urgency
1/10

Why it matters

Reports a potential mechanism for aspirin's anti-tumor activity in multiple myeloma.

Sources

Report an issue